Related references
Note: Only part of the references are listed.Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA
Erik N. Bergstrom et al.
NATURE (2022)
Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes
Vincent L. Cannataro et al.
MOLECULAR BIOLOGY AND EVOLUTION (2022)
Substitution mutational signatures in whole-genome-sequenced cancers in the UK population
Andrea Degasperi et al.
SCIENCE (2022)
Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers
Rachel A. DeWeerd et al.
CELL REPORTS (2022)
Mechanisms of APOBEC3 mutagenesis in human cancer cells
Mia Petljak et al.
NATURE (2022)
Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB
Manikandan Periyasamy et al.
ONCOGENE (2021)
An extended APOBEC3A mutation signature in cancer
Adam Langenbucher et al.
NATURE COMMUNICATIONS (2021)
Single-stranded DNA binding proteins influence APOBEC3A substrate preference
Amber L. Brown et al.
SCIENTIFIC REPORTS (2021)
Genomic profile of advanced breast cancer in circulating tumour DNA
Belinda Kingston et al.
NATURE COMMUNICATIONS (2021)
Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution
Subramanian Venkatesan et al.
CANCER DISCOVERY (2021)
Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells
Josep Biayna et al.
PLOS BIOLOGY (2021)
Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity
Abby M. Green et al.
EMBO REPORTS (2021)
A body map of somatic mutagenesis in morphologically normal human tissues
Ruoyan Li et al.
NATURE (2021)
Learning mutational signatures and their multidimensional genomic properties with TensorSignatures
Harald Vohringer et al.
NATURE COMMUNICATIONS (2021)
Genotoxic stress and viral infection induce transient expression of APOBEC3A and pro-inflammatory genes through two distinct pathways
Sunwoo Oh et al.
NATURE COMMUNICATIONS (2021)
APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis
Sonja M. Wormann et al.
NATURE CANCER (2021)
Prevalence and mutational determinants of high tumor mutation burden in breast cancer
R. Barroso-Sousa et al.
ANNALS OF ONCOLOGY (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Tobacco smoking and somatic mutations in human bronchial epithelium
Kenichi Yoshida et al.
NATURE (2020)
The evolutionary history of 2,658 cancers
Moritz Gerstung et al.
NATURE (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
Christopher B. Driscoll et al.
NATURE COMMUNICATIONS (2020)
Mutational signatures are jointly shaped by DNA damage and repair
Nadezda V. Volkova et al.
NATURE COMMUNICATIONS (2020)
The mutational landscape of normal human endometrial epithelium
Luiza Moore et al.
NATURE (2020)
Molecular origins of APOBEC-associated mutations in cancer
Mia Petljak et al.
DNA REPAIR (2020)
APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis
John Maciejowski et al.
NATURE GENETICS (2020)
DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers
David Mas-Ponte et al.
NATURE GENETICS (2020)
Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots
Pegah Jalili et al.
NATURE COMMUNICATIONS (2020)
HMCES Maintains Replication Fork Progression and Prevents Double-Strand Breaks in Response to APOBEC Deamination and Abasic Site Formation
Kavi P. M. Mehta et al.
CELL REPORTS (2020)
APOBEC3A catalyzes mutation and drives carcinogenesis in vivo
Emily K. Law et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead
Milaid Granadillo Rodriguez et al.
OPEN BIOLOGY (2020)
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis
Mia Petljak et al.
CELL (2019)
Polyomavirus T Antigen Induces APOBEC3B Expression Using an LXCXE-Dependent and TP53-Independent Mechanism
Gabriel J. Starrett et al.
MBIO (2019)
APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors
Nitin Roper et al.
CELL REPORTS (2019)
Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features
Remi Buisson et al.
SCIENCE (2019)
The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities
Abby M. Green et al.
DNA REPAIR (2019)
Inhibiting APOBEC3 Activity with Single-Stranded DNA Containing 2′-Deoxyzebularine Analogues
Maksim V. Kvach et al.
BIOCHEMISTRY (2019)
Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases
Joseph C. F. Ng et al.
NUCLEIC ACIDS RESEARCH (2019)
Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity
Adam Z. Cheng et al.
NATURE MICROBIOLOGY (2019)
APOBEC3A is a prominent cytidine deaminase in breast cancer
Luis M. Cortez et al.
PLOS GENETICS (2019)
Selective inhibition of APOBEC3 enzymes by single-stranded DNAs containing 2′-deoxyzebularine
Fareeda M. Barzak et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
Understanding the regulation of APOBEC3 expression: Current evidence and much to learn
Daniela Angela Covino et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response
Alexander P. Glaser et al.
ONCOTARGET (2018)
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
S. Venkatesan et al.
ANNALS OF ONCOLOGY (2018)
APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
Shixiang Wang et al.
ONCOGENE (2018)
APOBEC3A/B deletion polymorphism and cancer risk
Liv B. Gansmo et al.
CARCINOGENESIS (2018)
APOBEC Enzymes as Targets for Virus and Cancer Therapy
Margaret E. Olson et al.
CELL CHEMICAL BIOLOGY (2018)
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
June-Koo Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53
Daniel Menendez et al.
MOLECULAR CANCER RESEARCH (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation
Xiao Xiao et al.
NUCLEIC ACIDS RESEARCH (2017)
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells
Manikandan Periyasamy et al.
NUCLEIC ACIDS RESEARCH (2017)
Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
Cody J. Warren et al.
VIRUSES-BASEL (2017)
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
Eric Letouze et al.
NATURE COMMUNICATIONS (2017)
The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population
Katarzyna Klonowska et al.
ONCOTARGET (2017)
Cytosine Deaminase APOBEC3A Sensitizes Leukemia Cells to Inhibition of the DNA Replication Checkpoint
Abby M. Green et al.
CANCER RESEARCH (2017)
APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition
Remi Buisson et al.
CANCER RESEARCH (2017)
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair
Nicholas J. Haradhvala et al.
CELL (2016)
APOBEC3A damages the cellular genome during DNA replication
Abby M. Green et al.
CELL CYCLE (2016)
APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication
Vladimir B. Seplyarskiy et al.
GENOME RESEARCH (2016)
Conservation and Innovation of APOBEC3A Restriction Functions during Primate Evolution
Richard N. McLaughlin et al.
MOLECULAR BIOLOGY AND EVOLUTION (2016)
Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors
Candace D. Middlebrooks et al.
NATURE GENETICS (2016)
Mutational signatures associated with tobacco smoking in human cancer
Ludmil B. Alexandrov et al.
SCIENCE (2016)
The APOBEC Protein Family: United by Structure, Divergent in Function
Jason D. Salter et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis
Gabriel J. Starrett et al.
NATURE COMMUNICATIONS (2016)
The topography of mutational processes in breast cancer genomes
Sandro Morganella et al.
NATURE COMMUNICATIONS (2016)
APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication
James I. Hoopes et al.
CELL REPORTS (2016)
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer
Emily K. Law et al.
SCIENCE ADVANCES (2016)
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer
Nnennaya Kanu et al.
GENOME BIOLOGY (2016)
Clusters of Multiple Mutations: Incidence and Molecular Mechanisms
Kin Chan et al.
ANNUAL REVIEW OF GENETICS, VOL 49 (2015)
The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers
Brandon Leonard et al.
CANCER RESEARCH (2015)
Oxidative Reactivities of 2-Furylquinolines: Ubiquitous Scaffolds in Common High-Throughput Screening Libraries
Margaret E. Olson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
Kin Chan et al.
NATURE GENETICS (2015)
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
Charles Swanton et al.
CANCER DISCOVERY (2015)
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer
Manikandan Periyasamy et al.
CELL REPORTS (2015)
Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer
Reuben S. Harris
BREAST CANCER RESEARCH (2015)
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
Serena Nik-Zainal et al.
NATURE GENETICS (2014)
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Elza C. de Bruin et al.
SCIENCE (2014)
A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3′UTR enhances chromosomal DNA damage
Vincent Caval et al.
NATURE COMMUNICATIONS (2014)
APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development
Stephen Henderson et al.
CELL REPORTS (2014)
Break-Induced Replication Is a Source of Mutation Clusters Underlying Kataegis
Cynthia J. Sakofsky et al.
CELL REPORTS (2014)
Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers
Anieta M. Sieuwerts et al.
HORMONES & CANCER (2014)
APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry
Dennis Xuan et al.
CARCINOGENESIS (2013)
Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination
Lela Lackey et al.
CELL CYCLE (2013)
A Common Deletion in the APOBEC3 Genes and Breast Cancer Risk
Jirong Long et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
APOBEC3B is an enzymatic source of mutation in breast cancer
Michael B. Burns et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
APOBEC3B mutagenesis in cancer
Kawai J. Kuong et al.
NATURE GENETICS (2013)
Evidence for APOBEC3B mutagenesis in multiple human cancers
Michael B. Burns et al.
NATURE GENETICS (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis
Benjamin J. M. Taylor et al.
ELIFE (2013)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
APOBEC3B and AID Have Similar Nuclear Import Mechanisms
Lela Lackey et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Clustered Mutations in Yeast and in Human Cancers Can Arise from Damaged Long Single-Strand DNA Regions
Steven A. Roberts et al.
MOLECULAR CELL (2012)
HIV Restriction Factors and Mechanisms of Evasion
Michael H. Malim et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1
Judd F. Hultquist et al.
JOURNAL OF VIROLOGY (2011)
Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction
Eric W. Refsland et al.
NUCLEIC ACIDS RESEARCH (2010)
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Fransje A. Koning et al.
JOURNAL OF VIROLOGY (2009)
The AID/APOBEC family of nucleic acid mutators
Silvestro G. Conticello
GENOME BIOLOGY (2008)
Population stratification of a common APOBEC gene deletion polymorphism
Jeffrey M. Kidd et al.
PLOS GENETICS (2007)
APOBEC3 inhibits mouse mammary tumour virus replication in vivo
Chioma M. Okeoma et al.
NATURE (2007)
Mice deficient in APOBEC2 and APOBEC3
MC Mikl et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses
C Esnault et al.
NATURE (2005)
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
SL Sawyer et al.
PLOS BIOLOGY (2004)
Rapid evolution of primate antiviral enzyme APOBEC3G
JZ Zhang et al.
HUMAN MOLECULAR GENETICS (2004)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators
RS Harris et al.
MOLECULAR CELL (2002)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Share Paper
